BrentonJNKimJSchwartzRH. Approach to the management of pediatric-onset anti-N-methyl-d-aspartate (anti-NMDA) receptor encephalitis: a case series. J Child Neurol. 2016;31:1150–1155.
2.
NagappaMBinduPSMahadevanASinhaSMathuranathPSTalyAB. Clinical features, therapeutic response, and follow-up in pediatric anti-N-methyl-d-aspartate receptor encephalitis: experience from a tertiary care university hospital in India. Neuropediatrics. 2016;47(1):24–32.
3.
ArmangueTTitulaerMJMalagaI. Pediatric anti-N-methyl-d-aspartate receptor encephalitis—clinical analysis and novel findings in a series of 20 patients. J Pediatr. 2013;162:850–6.e2.
4.
FloranceNRDavisRLLamC. Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66:11–18.
5.
TitulaerMJMcCrackenLGabilondoI. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157–165.
